Condition: Ankylosing Spondylitis · Rheumatic Arthritis · Systemic Lupus Erythematosus · Sponsor: Universidade Nova de Lisboa
Ankylosing spondylitis (AS), Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) are three diseases where early diagnosis remains a major challenge. However, early diagnosis is the main determinant for a better prognosis. In the early stage, symptoms may be nonspecific and often difficult to establish a differential diagnosis between rheumatic diseases and other diseases, namely infectious and cancer diseases.
This description comes directly from the study's public registry record.
Fernando Pimentel-Santos, PhD Agg · 00351917305093 · pimentel.santos@nms.unl.pt
Ian Lopes Teixeira, MSc · 00351926234952 · ian.teixeira@nms.unl.pt
Always discuss trial participation with your own doctor first.
| ULS Lisboa Ocidental, Hospital de Egas Moniz | Lisbon, Portugal | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06778343